SUMMARY OF THE PRODUCT CHARACTERISTICS

Similar documents
[Version 8, 10/2012] SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

PART IB1 SUMMARY OF PRODUCT CHARACTERISTICS OCTACILLIN

FLOXYME 50 mg/ml SOLUTION FOR USE IN DRINKING WATER

Summary of Product Characteristics

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS. 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Vetrisulf powder for oral solution for chickens, turkeys and geese

SUMMARY OF PRODUCT CHARACTERISTICS 1.B.1 SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS. NUFLOR 300 mg/ml solution for injection for cattle and sheep

SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

Ubroseal Dry Cow 2.6 g intramammary suspension for cattle

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised

4.5. Special precautions for use Special precautions to be taken by person administering the veterinary medicinal product to animals

Summary of Product Characteristics

[Version 7.2, 12/2008] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

[Version 8.1,01/2017] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1/12

Summary of Product Characteristics

B. PACKAGE LEAFLET 1

SUMMARY OF PRODUCT CHARACTERISTICS. Cephacare flavour 50 mg tablets for cats and dogs. Excipients: For a full list of excipients, see section 6.1.

LABELLING AND PACKAGE LEAFLET

SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics

SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Vetoquinol/DOLPAC Small dogs/european Renewal June 2011 SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS. Pentoject, Pentobarbitone Sodium 200 mg/ml Solution for Injection

SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

For the treatment of infections caused by a wide range of Gram-positive and Gramnegative pathogenic bacteria including:

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS. Pharmasin 250 mg/g Premix for medicated feeding stuff for pigs, broilers and pullets

SUMMARY OF PRODUCT CHARACTERISTICS. Bottle of powder: Active substance: ceftiofur sodium mg equivalent to ceftiofur...

Irish Medicines Board

Summary of Product Characteristics

ANNEX III LABELLING AND PACKAGE LEAFLET

Part II SUMMARY OF PRODUCT CHARACTERISTICS. Each tablet contains 25 mg Clindamycin (as Clindamycin Hydrochloride)

Summary of Product Characteristics

SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

[Version 8, 10/2012] ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY of PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS. Vetmulin 450 mg/g granules for use in drinking water for pigs. (All MS except FR)

SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS. 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Emdocam 20 mg/ml solution for injection for cattle, pigs and horses

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised

SUMMARY OF PRODUCT CHARACTERISTICS

Doxivex, 100 mg/ml concentrate for oral solution for chickens and pigs

Summary of Product Characteristics

Health Products Regulatory Authority

Summary of Product Characteristics

SUMMARY OF PRODUCT CHARACTERISTICS. Equest Oral Gel, 18,92 mg/g, Oral Gel for Horses and Ponies

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

Irish Medicines Board

Summary of Product Characteristics

LUTEOSYL(d)-Cloprostenol mg/ml Solution for injection for cattle and pigs

BOX 1. NAME OF THE VETERINARY MEDICINAL PRODUCT. Hymatil 300 mg/ml solution for injection for cattle and sheep Tilmicosin

SUMMARY OF PRODUCT CHARACTERISTICS

For the treatment and prevention of infections caused by:

Summary of Product Characteristics

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

B. PACKAGE LEAFLET 1

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS. Active substance: cefalexin (as cefalexin monohydrate) mg

1. NAME OF THE VETERINARY MEDICINAL PRODUCT

SUMMARY OF PRODUCT CHARACTERISTICS. Animeloxan 1.5 mg/ml oral suspension for dogs. Active substance: Meloxicam 1.5 mg (equivalent to 0.

Summary of Product Characteristics

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

Ear drops suspension. A smooth, uniform, white to off-white viscous suspension.

SUMMARY OF PRODUCTS CHARACTERISTICS

Tablet. A light-brown to brown, meat flavoured, bone shaped tablet scored on both sides that can be divided into halves.

SUMMARY OF PRODUCT CHARACTERISTICS. Procaine penicillin Dihydrostreptomycin Sulfate

Transcription:

1 SUMMARY OF THE PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Exflow 10 mg/g powder for use in drinking water for cattle (calves), pigs, chickens, turkeys and ducks Exflow Vet 10 mg/g powder for use in drinking water for cattle (calves), pigs, chickens, turkeys and ducks (BE/DE/AT/NL) Exflow (FR) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each gram contains: Active substance: Bromhexine... 9.11 mg (as bromhexine hydrochloride 10.00 mg) Excipients: For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Powder for use in drinking water White to slightly beige powder 4. CLINICAL PARTICULARS 4.1 Target species Cattle (Calves), pigs, chickens, turkeys and ducks. 4.2 Indications for use, specifying the target species Mucolytic treatment of congested respiratory tract. 4.3 Contraindications Do not use in cases of pulmonary oedema. In case of serious lungworm infection, the drug should only be used 3 days after the commencement of the anthelmintic treatment. Do not use in cases of hypersensitivity to the active substance or to any of the excipients. 4.4 Special warnings for each target species None. 4.5 Special precautions for use Special precautions to be taken by the person administering the veterinary medicinal product to animals People with known hypersensitivity to bromhexine or any of the excipients should avoid contact with the veterinary medicinal product. Avoid contact with skin and eyes.

In case of accidental eye contact, flush the affected eye with copious amounts of clean running water. Wash hands and exposed skin after administering the product. 2 4.6 Adverse reactions (frequency and seriousness) None known 4.7 Use during pregnancy, lactation or lay Studies in laboratory animals have not produced evidence of foetotoxic effects or effects on fertility at the recommended dose. However this has not been specifically studied in the target species. Use only according to the benefit-risk assessment by the responsible veterinarian. 4.8 Interaction with other medicinal products and other forms of interaction The product may be used in conjunction with antibiotics and/or sulphonamides and bronchodilators. Bromhexine modifies the distribution of antibiotics in the organism and increases their concentration in the respiratory system. 4.9 Amounts to be administered and administration route To be administered orally 0.45 mg of bromhexine per kg bodyweight daily, equivalent to 5 g of product per 100 kg bodyweight per day administered for 3 to 10 consecutive days, in drinking water. In order to obtain the correct dosage the concentration of bromhexine has to be adjusted accordingly. The following formula may be used to calculate the required concentration of product (in milligrams of product per litre drinking water): 50.mg of the product per kg body weight and per day x Average body weight (kg) of animals to be treated =... mg of the product per litre of drinking water Average daily water intake (l/animal) The required amount of product should be weighed as accurately as possible using suitably calibrated weighing equipment. Recommendation for dilution: Prepare a relevant quantity of water in a container. Add the product to the water while stirring the solution. Prepare the solution with fresh water immediately before use. When using a water proportionner, adjust the pump between 1% to 5% and adapt the volume of preparation accordingly. Do not set up the dosing pump below 1%. When using a water tank, it is recommended to prepare a stock solution of at least 1g of product/l and to dilute it to the target final concentration.

The solubility of the product has been tested at the maximum concentration of 100 g/l at 20 C. Turn off the water supply to the tank until all the medicated solution is consumed. For example : Prepare a stock solution at 1 g of product/l, dilute 1/3 to obtain a medicated solution at 0.33g of powder/l eq to 1g of powder/3l. For pigs, when administered during the meal, first dissolve the product in water and then add feed. Administration during the meal should be restricted to individual treatment or for treatment of a small group of animals. The preparation must be used immediately. Care should be taken that the intended dose will be completely ingested. The intake of medicated water depends on the clinical condition of the animals. Any unused medicated water should be discarded after 24 hours. 3 4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary None known. 4.11 Withdrawal period(s) Cattle (calves) Meat and offal: 2 days Not permitted for use in cows producing milk for human consumption. Pigs Meat and offal: Zero days. Chickens, turkeys and ducks Meat and offal: Zero days Do not use in birds producing eggs for consumption, during and 4 weeks before the laying phase. 5. PHARMACOLOGICAL PROPERTIES Pharmacotherapeutic group: mucolytics. ATCvet code: QR05CB02. Expectorants, excl. combinations with cough suppressants, 5.1 Pharmacodynamic properties Bromhexine is a mucoregulator. By activating the secretion of the seromucous glands, bromhexine helps to re-establish the viscosity and elasticity of bronchial secretions in the tracheobronchial tree. In addition, its expectorant action encourages mobilisation of mucus and enables effective bronchial drainage, thereby improving the functioning and defence capability of the lung. These two simultaneous actions lead to an abundant discharge and facilitate a productive cough. It breaks down the network of acid glycoprotein fibres found in mucoid sputum, which are mainly responsible for the characteristic viscosity. Bromhexine modifies the distribution of antibiotics in the organism and increases their concentration in the serum and in the nasal secretions (e.g. spiramycin, tylosin and oxytetracycline). When administered concomitantly with the product, antimicrobial agents should, nevertheless, not be underdosed.

4 5.2 Pharmacokinetic particulars Absorption In pigs, bromhexine is rapidly absorbed following oral administration with a peak plasma concentrations obtained in one to three hours. The concentration plateau is reached 12 hours after the second or third administration. In cattle, plasma concentrations increase progressively over several hours following administration. In turkeys or broilers, peak plasma concentrations are reached within 2 to 4 hours of oral administration. Distribution Due to the lipophilic character of bromhexine, it has a strong affinity for lipid tissues and a slow depletion profile from these tissues. Metabolism Bromhexine is largely metabolised into more polar compounds. Elimination The apparent total radioactivity plasma half-life elimination after the last administration is 20 to 30 hours in a pig, 40 to 50 hours in cattle and 40 to 50 hours in chickens and turkeys. 6. PHARMACEUTICAL PARTICULARS 6.1 List of excipients Citric acid anhydrous Lactose monohydrate 6.2 Incompatibilities In the absence of compatibility studies, this veterinary medicinal product must not be mixed with other veterinary medicinal products. 6.3 Shelf life Shelf life of the veterinary medicinal product as packaged for sale: 3 years Shelf life after first opening the immediate packaging: 3 months Shelf life after dilution in drinking water: 24 hours 6.4. Special precautions for storage This veterinary medicinal product does not require any special storage conditions. 6.5 Nature and composition of immediate packaging Polyethylene/ polyamide/ aluminium/ polyethylene terephthalate bags closed by a zip: 500 g, 1 kg, 2.5kg, 5kg White HDPE jars with a yellow polypropylene screw stopper: 500 g,1 kg Not all pack sizes may be marketed.

6.6 Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements. 7. MARKETING AUTHORISATION HOLDER 5 8. MARKETING AUTHORISATION NUMBER(S) 9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION 10 DATE OF REVISION OF THE TEXT

6 Labelling -Package leaflet Exflow 10 mg/g powder for use in drinking water for cattle (calves), pigs, chickens, turkeys and ducks Exflow Vet 10 mg/g powder for use in drinking water for cattle (calves), pigs, chickens, turkeys and ducks (BE/DE/AT/NL) Exflow (FR) 1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT Marketing authorisation holder: Manufacturer responsible for batch release: laboratoires BIOVE 3 rue de lorraine 62510 Arques France Ceva Santé Animale Boulevard de la Communication Zone Autoroutière 53950 LOUVERNE France 2. NAME OF THE VETERINARY MEDICINAL PRODUCT Exflow 10 mg/g powder for use in drinking water for cattle (calves), pigs, chickens, turkeys and ducks Exflow Vet 10 mg/g powder for use in drinking water for cattle (calves), pigs, chickens, turkeys and ducks (BE/DE/AT/NL) Exflow (FR) Bromhexine hydrochloride 3. STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S) Each gram contains: Active substance: Bromhexine... 9.11 mg (as bromhexine hydrochloride 10.00 mg) Powder for use in drinking water White to slightly beige powder 4. INDICATION(S) Mucolytic treatment of congested respiratory tract. 5. CONTRAINDICATIONS Do not use in cases of pulmonary oedema. In case of serious lungworm infection, the drug should only be used 3 days after the commencement of the anthelmintic treatment. Do not use in cases of hypersensitivity to the active substance or to any of the excipients.

7 6. ADVERSE REACTIONS None known. If you notice any serious effects or other effects not mentioned in this package leaflet, please inform your veterinary surgeon. 7. TARGET SPECIES Cattle (Calves), pigs, chickens, turkeys and ducks. 8. DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION To be administered orally 0.45 mg of bromhexine per kg bodyweight daily, equivalent to 5 g of product per 100 kg bodyweight per day administered for 3 to 10 consecutive days, in drinking water. In order to obtain the correct dosage the concentration of bromhexine has to be adjusted accordingly. The following formula may be used to calculate the required concentration of product (in milligrams of product per litre drinking water):: 50.mg of the product per kg body weight and per day x Average body weight (kg) of animals to be treated =... mg of the product per litre of drinking water Average daily water intake (l/animal) The required amount of product should be weighed as accurately as possible using suitably calibrated weighing equipment. 9. ADVICE ON CORRECT ADMINISTRATION Recommendation for dilution: Prepare a relevant quantity of water in a container. Add the product to the water while stirring up the solution. Prepare the solution with fresh water immediately before use. When using a water proportionner, adjust the pump between 1% to 5% and adapt the volume of preparation accordingly. Do not set up the dosing pump below 1%. When using a water tank, it is recommended to prepare a stock solution of at least 1g of product/l and to dilute it to the target final concentration. The solubility of the product has been tested at the maximum concentration of 100 g/l at 20 C. Turn off the water supply to the tank until all the medicated solution is consumed. For example : Prepare a stock solution at 1 g of product/l, dilute 1/3 to obtain a medicated solution at 0.33g of powder/l eq to 1g of powder/3l. For pigs, when administered during the meal, first dissolve the product in water and then add feed. Administration during the meal should be restricted to individual treatment or for treatment of a small group of animals. The preparation must be used immediately. Care should be taken that the intended dose will be completely ingested.

8 The intake of medicated water depends on the clinical condition of the animals. Any unused medicated water should be discarded after 24 hours. 10. WITHDRAWAL PERIOD Cattle (calves) Meat and offal: 2 days Not permitted for use in cows producing milk for human consumption. Pigs Meat and offal: Zero days. Chickens, turkeys and ducks Meat and offal: Zero days Do not use in birds producing eggs for consumption, during and 4 weeks before the laying phase. 11. SPECIAL STORAGE PRECAUTIONS Keep out of the sight and reach of children. Shelf life after first opening the immediate packaging: 3 months Shelf life after dilution in drinking water: 24 hours This veterinary medicinal product does not require any special storage conditions. Do not use this veterinary medicinal product after the expiry date which is stated on the label. 12. SPECIAL WARNING(S) User Warnings People with known hypersensitivity to bromhexine or any of the excipients should avoid contact with the veterinary medicinal product. Avoid contact with skin and eyes. In case of accidental eye contact, flush the affected eye with copious amounts of clean running water. Wash hands and exposed skin after administering the product. Use during pregnancy, lactation or lay Studies in laboratory animals have not produced evidence of foetotoxic effects or effects on fertility at the recommended dose. However this has not been specifically studied in the target species. Use only according to the benefit-risk assessment by the responsible veterinarian. Interaction with other medicinal products and other forms of interaction The product may be used in conjunction with antibiotics and/or sulphonamides and bronchodilators. Bromhexine modifies the distribution of antibiotics in the organism and increases their concentration in the respiratory system. Overdose (symptoms, emergency procedures, antidotes), if necessary None known. Incompatibilities In the absence of compatibility studies, this veterinary medicinal product must not be mixed with other veterinary medicinal products.

9 13. SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE MATERIALS, IF ANY Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements. 14. DATE ON WHICH THE PACKAGE LEAFLET WAS LAST APPROVED 15. OTHER INFORMATION Bags of 500 g - 1 kg - 2.5kg - 5kg Jars of 500 g -1 kg Not all pack sizes may be marketed. For any information about this veterinary medicinal product, please contact the local representative of the marketing authorisation holder. MA number: For animal treatment only. To be supplied only on veterinary prescription BATCH NUMBER: EXPIRY DATE: